1. BioElectrics007
2. dsrjane
3. ItsNewman
4. SaulGoodman
5. JasonJohnJacobs
1.SaulGoodman 03/09/2018
SunTrust Robinson Humphrey raises PT to $40
2.JasonJohnJacobs 07/24/2018
MRTX to present updated data from two studies on sitravatinib
3.BioElectrics007 09/24/2017
Our money counterparts and ventures will be adequate meet our expected commitments for no less than 1 year... Ought to be set for cash.... descent job by timing it with next week's abstract if done
4.ItsNewman 09/24/2017
May be heavily shorted on Monday to get it below that mark....
5.ItsNewman 01/08/2018
We have news - BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region
6.BioElectrics007 09/24/2017
Ended at the opening from the big gap
7.ItsNewman 03/05/2018
8.dsrjane 03/05/2018
Looking hopeful
9.llttrusb1a60o2 03/05/2018
10.SaulGoodman 03/12/2018
Barclays initiates as an overweight, $44PT
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW